News - Page 133 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Awakn Life Sciences Strengthens Executive Leadership Team

Awakn Life Sciences Strengthens Executive Leadership Team

Post published:November 30, 2021
Post category:Press Release

Read more about the article PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio

PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio

Post published:November 30, 2021
Post category:Press Release

Read more about the article Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress

Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress

Post published:November 30, 2021
Post category:Press Release

Read more about the article MindMed and Liechti Lab publish first human data on the interacting effects of an SSRI and psilocybin

MindMed and Liechti Lab publish first human data on the interacting effects of an SSRI and psilocybin

Post published:November 30, 2021
Post category:Press Release

Read more about the article Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseases

Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseases

Post published:November 30, 2021
Post category:Press Release

Read more about the article MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation

MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation

Post published:November 30, 2021
Post category:Press Release

Read more about the article Red Light Holland Reports Second Quarter 2021 Results

Red Light Holland Reports Second Quarter 2021 Results

Post published:November 29, 2021
Post category:Press Release

Read more about the article Wesana Health Reports Q3 2021 Financial Results

Wesana Health Reports Q3 2021 Financial Results

Post published:November 29, 2021
Post category:Press Release

Read more about the article Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans

Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans

Post published:November 29, 2021
Post category:Press Release

Read more about the article Albert Labs (CSE: ABRT) Receive Conditional Approval for CSE Listing & Appoint Chrystal Capital Partners to Advise on European Listing

Albert Labs (CSE: ABRT) Receive Conditional Approval for CSE Listing & Appoint Chrystal Capital Partners to Advise on European Listing

Post published:November 29, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.